Advertisement

Acta Neurochirurgica

, Volume 161, Issue 10, pp 2059–2064 | Cite as

Technical note: accuracy and precision in stereotactic stem cell transplantation

  • David SatzerEmail author
  • Peter C. Warnke
Technical Note - Functional Neurosurgery - Other
  • 34 Downloads
Part of the following topical collections:
  1. Functional Neurosurgery – Other

Abstract

Background

While multiple trials have employed stereotactic stem cell transplantation, injection techniques have received little critical attention. Precise cell delivery is critical for certain applications, particularly when targeting deep nuclei.

Methods

Ten patients with a history of ischemic stroke underwent CT-guided stem cell transplantation. Cells were delivered along 3 tracts adjacent to the infarcted area. Intraoperative air deposits and postoperative T2-weighted MRI fluid signals were mapped in relation to calculated targets.

Results

The deepest air deposit was found 4.5 ± 1.0 mm (mean ± 2 SEM) from target. The apex of the T2-hyperintense tract was found 2.8 ± 0.8 mm from target. On average, air pockets were found anterior (1.2 ± 1.1 mm, p = 0.04) and superior (2.4 ± 1.0 mm, p < 0.001) to the target; no directional bias was noted for the apex of the T2-hyperintense tract. Location and distribution of air deposits were variable and were affected by the relationship of cannula trajectory to stroke cavity.

Conclusions

Precise stereotactic cell transplantation is a little-studied technical challenge. Reflux of cell suspension and air, and the structure of the injection tract affect delivery of cell suspensions. Intraoperative CT allows assessment of delivery and potential trajectory correction.

Keywords

Image guidance Intraoperative CT Stem cell Stereotaxy 

Notes

Funding

No funding was received for this research.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the University of Chicago Institutional Review Board (IRB#15-1409) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

References

  1. 1.
    Amer MH, Rose FRAJ, Shakesheff KM, Modo M, White LJ (2017) Translational considerations in injectable cell-based therapeutics for neurological applications: concepts, progress and challenges. NPJ Regen Med 2:23.  https://doi.org/10.1038/s41536-017-0028-x CrossRefGoogle Scholar
  2. 2.
    Bachoud-Lévi AC, Rémy P, Nguyen JP, Brugières P, Lefaucheur JP, Bourdet C, Baudic S, Gaura V, Maison P, Haddad B, Boissé MF, Grandmougin T, Jény R, Bartolomeo P, Dalla Barba G, Degos JD, Lisovoski F, Ergis AM, Pailhous E, Cesaro P, Hantraye P, Peschanski M (2000) Motor and cognitive improvements in patients with Huntington’s disease after neural transplantation. Lancet 356:1975–1979CrossRefGoogle Scholar
  3. 3.
    Burchiel KJ, McCartney S, Lee A, Raslan AM (2013) Accuracy of deep brain stimulation electrode placement using intraoperative computed tomography without microelectrode recording. J Neurosurg 119:301–306.  https://doi.org/10.3171/2013.4.jns122324 CrossRefGoogle Scholar
  4. 4.
    Chen J, Lanza GM, Wickline SA (2010) Quantitative magnetic resonance fluorine imaging: today and tomorrow. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2:431–440.  https://doi.org/10.1002/wnan.87 CrossRefGoogle Scholar
  5. 5.
    Deda H, Inci MC, Kürekçi AE, Sav A, Kayihan K, Ozgün E, Ustünsoy GE, Kocabay S (2009) Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy 11:18–25.  https://doi.org/10.1080/14653240802549470 CrossRefGoogle Scholar
  6. 6.
    Dunnett SB, Björklund A, Lindvall O (2001) Cell therapy in Parkinson’s disease - stop or go? Nat Rev Neurosci 2:365–369.  https://doi.org/10.1038/35072572 CrossRefGoogle Scholar
  7. 7.
    Focke A, Schwarz S, Foerschler A, Scheibe J, Milosevic J, Zimmer C, Schwarz J (2008) Labeling of human neural precursor cells using ferromagnetic nanoparticles. Magn Reson Med 60:1321–1328.  https://doi.org/10.1002/mrm.21745 CrossRefGoogle Scholar
  8. 8.
    Freed CR, Greene PE, Breeze RE, Tsai WY, DuMouchel W, Kao R, Dillon S, Winfield H, Culver S, Trojanowski JQ, Eidelberg D, Fahn S (2001) Transplantation of embryonic dopamine neurons for severe Parkinson’s disease. N Engl J Med 344:710–719.  https://doi.org/10.1056/NEJM200103083441002 CrossRefGoogle Scholar
  9. 9.
    Kondziolka D, Steinberg GK, Wechsler L, Meltzer CC, Elder E, Gebel J, Decesare S, Jovin T, Zafonte R, Lebowitz J, Flickinger JC, Tong D, Marks MP, Jamieson C, Luu D, Bell-Stephens T, Teraoka J (2005) Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg 103:38–45.  https://doi.org/10.3171/jns.2005.103.1.0038 CrossRefGoogle Scholar
  10. 10.
    Lindvall O, Björklund A (2004) Cell therapy in Parkinson’s disease. NeuroRx 1:382–393.  https://doi.org/10.1602/neurorx.1.4.382 CrossRefGoogle Scholar
  11. 11.
    Mink JW, Blumenschine RJ, Adams DB (1981) Ratio of central nervous system to body metabolism in vertebrates: its constancy and functional basis. Am J Phys 241:R203–R212.  https://doi.org/10.1152/ajpregu.1981.241.3.R203 Google Scholar
  12. 12.
    Mirzadeh Z, Chapple K, Lambert M, Dhall R, Ponce FA (2014) Validation of CT-MRI fusion for intraoperative assessment of stereotactic accuracy in DBS surgery. Mov Disord 29:1788–1795.  https://doi.org/10.1002/mds.26056 CrossRefGoogle Scholar
  13. 13.
    Olanow CW, Goetz CG, Kordower JH, Stoessl AJ, Sossi V, Brin MF, Shannon KM, Nauert GM, Perl DP, Godbold J, Freeman TB (2003) A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson’s disease. Ann Neurol 54:403–414.  https://doi.org/10.1002/ana.10720 CrossRefGoogle Scholar
  14. 14.
    Potts MB, Silvestrini MT, Lim DA (2013) Devices for cell transplantation into the central nervous system: design considerations and emerging technologies. Surg Neurol Int 4:S22–S30.  https://doi.org/10.4103/2152-7806.109190 Google Scholar
  15. 15.
    Schumacher JM, Ellias SA, Palmer EP, Kott HS, Dinsmore J, Dempsey PK, Fischman AJ, Thomas C, Feldman RG, Kassissieh S, Raineri R, Manhart C, Penney D, Fink JS, Isacson O (2000) Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 54:1042–1050CrossRefGoogle Scholar
  16. 16.
    Silvestrini MT, Yin D, Martin AJ, Coppes VG, Mann P, Larson PS, Starr PA, Zeng X, Gupta N, Panter SS, Desai TA, Lim DA (2015) Interventional magnetic resonance imaging-guided cell transplantation into the brain with radially branched deployment. Mol Ther 23:119–129.  https://doi.org/10.1038/mt.2014.155 CrossRefGoogle Scholar
  17. 17.
    Slaughter BV, Khurshid SS, Fisher OZ, Khademhosseini A, Peppas NA (2009) Hydrogels in regenerative medicine. Adv Mater 21:3307–3329.  https://doi.org/10.1002/adma.200802106 CrossRefGoogle Scholar
  18. 18.
    van Horne CG, Quintero JE, Gurwell JA, Wagner RP, Slevin JT, Gerhardt GA (2017) Implantation of autologous peripheral nerve grafts into the substantia nigra of subjects with idiopathic Parkinson’s disease treated with bilateral STN DBS: a report of safety and feasibility. J Neurosurg 126:1140–1147.  https://doi.org/10.3171/2016.2.JNS151988 CrossRefGoogle Scholar
  19. 19.
    Wang S, Karakatsani ME, Fung C, Sun T, Acosta C, Konofagou E (2017) Direct brain infusion can be enhanced with focused ultrasound and microbubbles. J Cereb Blood Flow Metab 37:706–714.  https://doi.org/10.1177/0271678X16637881 CrossRefGoogle Scholar
  20. 20.
    Yin D, Valles FE, Fiandaca MS, Bringas J, Gimenez F, Berger MS, Forsayeth J, Bankiewicz KS (2011) Optimal region of the putamen for image-guided convection-enhanced delivery of therapeutics in human and non-human primates. Neuroimage 54(Suppl 1):S196–S203.  https://doi.org/10.1016/j.neuroimage.2009.08.069 CrossRefGoogle Scholar
  21. 21.
    Yoon SH, Shim YS, Park YH, Chung JK, Nam JH, Kim MO, Park HC, Park SR, Min BH, Kim EY, Choi BH, Park H, Ha Y (2007) Complete spinal cord injury treatment using autologous bone marrow cell transplantation and bone marrow stimulation with granulocyte macrophage-colony stimulating factor: phase I/II clinical trial. Stem Cells 25:2066–2073.  https://doi.org/10.1634/stemcells.2006-0807 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of NeurosurgeryUniversity of ChicagoChicagoUSA

Personalised recommendations